Clinical Trial Update: Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

View source ↗

Summary

The University of Oxford is conducting a study to assess the immunogenicity of COVID-19 vaccines in patients with tuberculosis; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: University of Oxford | Conditions: Covid-19 Pandemics, Tuberculosis | Status: RECRUITING